-
公开(公告)号:AU2014348840A1
公开(公告)日:2016-05-26
申请号:AU2014348840
申请日:2014-11-12
Applicant: VERTEX PHARMA
Inventor: NTI-ADDAE KWAME W , WALDO MICHAEL , O'NEIL SIMON ADAM , VAN ALSTEN JOHN GREGG , MACIKENAS DAINIUS , MUDUNURI PRAVEEN , SHI YI , LEDEBOER MARK WILLEM , JURKAUSKAS VALDAS , MEDEK ALES , JONES STEVEN , BYRN RANDAL , ASMAL MOHAMMED , ROBERTSON SARAH MARIE , TSAI WANJUNG
IPC: C07D403/04 , A61K31/506 , A61P31/16 , C07D471/04
Abstract: Polymorphic forms of Compound (1) or a pharmaceutically acceptable salt thereof, wherein Compound (1) is represented by the following structural formula: are Form A of HCl salt of Compound (1)·1/2&EEgr;
-
公开(公告)号:NZ595817A
公开(公告)日:2014-03-28
申请号:NZ59581710
申请日:2010-04-27
Applicant: VERTEX PHARMA
Inventor: LOOKER ADAM , CHEN MINZHANG , JURKAUSKAS VALDAS , TANOURY GERALD J , COCHRAN JOHN E
IPC: C07D209/52 , A61K31/403 , C07D471/08 , C07K7/02
Abstract: 595817 Disclosed herein are processes for preparing a mixture of cis- and trans-octctahydropenta[c]pyrrole-1-carboxylic acids of formula 7, wherein R’ substituents are described in the specification, comprising carboxylation of an azabicyclooctane of formula 6, and equilibrating in the presence of a suitable base wherein the trans-/cis-ratio is greater than 80 to 20, or 90 to 10 or 98 to 2. Also disclosed herein are processes for preparing a compound of formula 4, comprising providing a compound of Formula 7 forming a salt with an optically active amine; crystallizing the salt; esterifying the acid provided in step iii); removing the N-alkoxycarbonyl group to produce (1S,3aR,6aS)-t-butyl-octahydrocyclopenta[c]pyrrole-1-carboxylate, t-butyl ester; reacting the bicyclic aminoester of step v) with a protected amino acid of Formula 26, wherein Z is an amine protecting group, in the presence of a coupling reagent, to produce an amide-ester of Formula 27; removing the protecting group Z from the amide-ester of step vi) to produce the amino compound of Formula 28; reacting the amino compound of Formula 28 with a protected amino acid of Formula 29in the presence of a coupling reagent to produce a tripeptide of Formula 30; removing the protecting group Z in the tripeptide of Formula 30 to produce a free amino-tripeptide of Formula 31; reacting the amino-tripeptide of Formula 31 with pyrazine-2-carboxylic acid in the presence of a coupling reagent to produce an amide-tripeptide ester of Formula 33; hydrolyzing the ester of the amide-tripeptide ester of Formula 33 to produce an amide-tripeptide acid of Formula 34; reacting the amide-tripeptide acid of Formula 34 with an aminohydroxy-amide of Formula 18in the presence of a coupling reagent to produce a hydroxy-tetrapeptide of Formula 35; and oxidizing the hydroxy group of Formula 35 to produce the compound of Formula 4.
-
公开(公告)号:AR087345A1
公开(公告)日:2014-03-19
申请号:ARP120102727
申请日:2012-07-26
Applicant: VERTEX PHARMA
Inventor: JURKAUSKAS VALDAS , RUGGIERO PIERO L , ROEPER STEFANIE , WILLCOX DAVID , WALDO MICHAEL , GUERETTE DAHRIKA MILFRED YAP , KLINE BILLIE J , LUONG HOA Q
IPC: C07D333/38 , A61K31/381 , A61P31/14 , C07D409/12
Abstract: También se reivindican métodos para obtener intermediarios. Los compuestos son útiles como antivirales.Reivindicación 1: Un método de preparación del compuesto (1) representado por la fórmula estructural (1), o una de sus sales farmacéuticamente aceptables, que comprende: a) hacer reaccionar el compuesto de fórmula (A) con 3,3-dimetilbut-1-ino en presencia de uno o varios catalizadores de paladio seleccionados del grupo que consiste en Pd(PPh3)4 y Pd(PPh3)2Cl2 y uno o varios catalizadores de cobre seleccionados del grupo que consiste en CuI, CuBr y CuCl para generar el compuesto de fórmula (B); b) tratar el compuesto de fórmula (B) con un ácido para generar el compuesto de fórmula (C); c) reducir la ciclohexanona del compuesto de fórmula (C) en ciclohexanol para generar el compuesto de fórmula (D) ;y d) hacer reaccionar el compuesto de fórmula (D) con una base para generar el compuesto de fórmula (1).
-
公开(公告)号:GEP20125645B
公开(公告)日:2012-09-25
申请号:GEAP2008011488
申请日:2008-02-27
Applicant: VERTEX PHARMA
Inventor: CONNELLY PATRICK R , KADIYALA IRINA , STAVROPOLUS KATHY , ZHANG YUEGANG , JOHNSTON STEVE , BHISETTI GOVINDA RAO , JURKAUSKAS VALDAS , ROSE PETER
IPC: C07D403/12 , A61K31/497 , A61K38/07 , C07K5/10
Abstract: The invention relates to compositions and co-crystals each comprising VX-950 and a co-crystal former selected from the group consisting of 4-hydroxybenzoic acid, 4-amino salicylic acid, phenylalanine, threonline, tartaric acid, adipic acid, succinic acetate, proline, methyl 4-hydroxybenzoate, anthranilic acid, and d-Biotin. Also within the scope of this invention are methods of making the same.
-
公开(公告)号:ZA201101477B
公开(公告)日:2012-07-25
申请号:ZA201101477
申请日:2011-02-24
Applicant: VERTEX PHARMA
Inventor: DOKOU ELENI , GASPARAC REHELA , KNEZIC DRAGUTIN , KLINE BILLIE , JURKAUSKAS VALDAS
IPC: A61K20060101
Abstract: An immediate release formulation of an active ingredient.
-
公开(公告)号:PT2114924E
公开(公告)日:2012-04-03
申请号:PT08726147
申请日:2008-02-27
Applicant: VERTEX PHARMA
Inventor: BHISETTI GOVINDA RAO , CONNELLY PATRICK R , KADIYALA IRINA , STAVROPOLUS KATHY , ZHANG YUEGANG , JOHNSTON STEVE , JURKAUSKAS VALDAS , ROSE PETER
IPC: C07D403/12 , A61K31/497 , A61K38/07 , C07K5/10
-
公开(公告)号:CA2735431A1
公开(公告)日:2010-03-11
申请号:CA2735431
申请日:2009-08-28
Applicant: VERTEX PHARMA
Inventor: DOKOU ELENI , GASPARAC REHELA , KNEZIC DRAGUTIN , KLINE BILLIE , JURKAUSKAS VALDAS
Abstract: An immediate release formulation of an active ingredient, wherein the active ingredient is a co-crystal of VX-950 and a 4-hydroxybenzoic acid.
-
公开(公告)号:AU2008219607A1
公开(公告)日:2008-09-04
申请号:AU2008219607
申请日:2008-02-27
Applicant: VERTEX PHARMA
Inventor: JURKAUSKAS VALDAS , ROSE PETER , ZHANG YUEGANG , JOHNSTON STEVE , BHISETTI GOVINDA RAO , STAVROPOLUS KATHY , KADIYALA IRINA , CONNELLY PATRICK R
IPC: C07D403/12 , A61K31/497 , A61K38/07 , C07K5/10
Abstract: The invention relates to compositions and co-crystals each comprising VX-950 and a co-crystal former selected from the group consisting of 4-hydroxybenzoic acid, 4-amino salicyclic acid, phenylalanine, threonline, tartaric acid, adipic acid, succinic acetate, proline, methyl 4-hydroxybenzoate, anthranilic acid, and d-Biotin. Also within the scope of this invention are methods of making and using the same.
-
公开(公告)号:SI3068776T1
公开(公告)日:2019-09-30
申请号:SI201431295
申请日:2014-11-12
Applicant: VERTEX PHARMA
Inventor: NTI-ADDAE KWAME W , WALDO MICHAEL , O'NEIL SIMON ADAM , VAN ALSTEN JOHN GREGG , MACIKENAS DAINIUS , MUDUNURI PRAVEEN , SHI YI , LEDEBOER MARK WILLEM , JURKAUSKAS VALDAS , MEDEK ALES , JONES STEVEN , BYRN RANDAL , ASMAL MOHAMMED , ROBERTSON SARAH MARIE , TSAI WANJUNG
IPC: C07D403/00 , A61K31/00 , A61P31/00 , C07D471/00
-
公开(公告)号:RS59144B1
公开(公告)日:2019-09-30
申请号:RSP20191054
申请日:2014-11-12
Applicant: VERTEX PHARMA
Inventor: NTI-ADDAE KWAME W , WALDO MICHAEL , O'NEIL SIMON ADAM , VAN ALSTEN JOHN GREGG , MACIKENAS DAINIUS , MUDUNURI PRAVEEN , SHI YI , LEDEBOER MARK WILLEM , JURKAUSKAS VALDAS , MEDEK ALES , JONES STEVEN , BYRN RANDAL , ASMAL MOHAMMED , ROBERTSON SARAH MARIE , TSAI WANJUNG
IPC: C07D403/04 , A61K31/506 , A61P31/16 , C07D471/04
-
-
-
-
-
-
-
-
-